Bakkt Holdings
BKKT
Mawson Infrastructure
MIGI
BIT Mining
BTCM
Riot Platforms
RIOT
The9 Ltd
NCTY
US Stock MarketDetailed Quotes
AMLX Amylyx Pharmaceuticals
- 3.650
- -0.080-2.14%
Close Mar 21 16:00 ET
- 3.830
- +0.180+4.93%
Post 19:43 ET
323.40MMarket Cap-0.82P/E (TTM)
3.805High3.630Low1.51MVolume3.680Open3.730Pre Close5.55MTurnover2.53%Turnover RatioLossP/E (Static)88.60MShares7.27052wk High1.96P/B217.11MFloat Cap1.57552wk Low--Dividend TTM59.48MShs Float41.930Historical High--Div YieldTTM4.69%Amplitude1.575Historical Low3.683Avg Price1Lot Size
Market Insights
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.
Amylyx Pharmaceuticals Stock Forum
Can Amylyx Recover? Q4 Results Show $301.7M Loss But Pipeline Progress and Extended Cash Runway
Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis
Amylyx Pharmaceuticals (NASDAQ: AMLX) announced that the FDA has lifted the clinical hold on its Phase 1 clinical trial of AMX0114, an antisense oligonucleotide targeting calpain-2 for ALS treatment. The company will proceed with opening U.S. sites for screening, enrollment, and dosing.
The Phase 1 LUMINA cl...
No comment yet